Encontramos 361 documentos que correspondem aos seus critérios de pesquisa

  1. Rousselot® Biomédica lança X-Pure® GelDAT, a primeira gelatina purificada e funcionalizada com fenol

    Irving, Texas, 20 de maio de 2021 – Rousselot®, uma marca da Darling Ingredients e líder global de soluções à base de colágeno 1 expande sua linha de gelatinas purificadas modificadas de grau médico com o lançamento de X-Pure® GelDAT – Gelatina Desaminotirosina. Criada em resposta ao pedido de um cl

  2. Rousselot® Biomedical lança Quali-Pure™

    A mais recente adição ao portfólio em rápida expansão da Rousselot Biomedical, Quali-Pure foi criado especificamente para uma série de aplicações, incluindo embolização, cicatrização de feridas, administração de medicamentos, vacinas e produtos hemostáticos. Quali-Pure oferece biocompatibilidade, bi

  3. Zerion Pharma ApS extends its licensing agreement with Rousselot B.V

    According to the revised license agreement, Rousselot grants Zerion Pharma an exclusive license to exploit the inventions covered by the patent family belonging to international patent application WO 2017/186889. The revision of the license agreement follows the recent grant of a key European Patent

  4. Rousselot Biomedical presentation highlights from the 31st conference of the European Society of Biomaterials conference 2021’

    Watch the session with Dr Leijten from the University of Twente and Dr Daelman from Rousselot Session discussion highlights include: The unique properties of Gelatin for 3D bioprinting: The use of gelatin to stably incorporate nanoparticles into printable bio-inks. The biocompatibility of Gelatin fo

  5. Highly purified X-Pure gelatin creates optimal environment for stem cell differentiation and minimizes immune response

    Highly purified X-Pure gelatin creates optimal environment for stem cell differentiation and minimizes immune response Biomaterial contamination with endotoxins (LPS) must be taken into account during in-vitro culturing applications Jos Olijve discusses 'Endotoxin & Cellular Activity' at the Society

  6. Antleron-Rousselot® collaborate to develop X-Pure®–by-Design

    The collaboration was initiated when Antleron’s BioScout® custom biomaterial screening was applied to Rousselot’s X-Pure® biomaterial platform. Today, to assist Rousselot in translating its cutting-edge biomaterial innovation, the collaboration has evolved to create a ‘Quality-by-Design’ framework w

  7. Presentations, conferences on X-Pure

    31st conference of the European Society of Biomaterials conference 2021 Session discussion highlights include: Speakers: Dr Jeroen Leijten, University of Twente, Enschede, Netherlands & Dr Jeff Daelman , Business Development Manager, Innovations at Rousselot Biomedical The unique properties of Gelat

  8. Videos on X-Pure range

    Watch our videos on X-Pure Endotoxins & cellular activity In biomedical R&D and clinical applications, endotoxins can trigger a strong fatal immune response. X-Pure GelMA minimizes the risk of prolonged or sustained inflamation caused by endotoxin exposure. Jos Olijve, Rousselot Scientific Support M

  9. Videos on X-Pure

    Watch our videos on X-Pure range Watch our presentations and conferences

  10. Rousselot® apresenta soluções versáteis de gelatina e colágeno com protótipos inovadores na Vitafoods 2021

    A conveniência somada aos benefícios funcionais: solução de gelatina SiMoGel para gomas fortificadas A mais recente solução SiMoGel da Rousselot revela o potencial das gomas funcionais de centro líquido para os setores nutracêutico e farmacêutico. Essas gomas com preenchimento central - também conhe